Aspartame
CAS No. 22839-47-0
Aspartame ( L-Aspartyl-L-Phenylalanine methyl ester )
Catalog No. M13628 CAS No. 22839-47-0
Aspartame is an artificial, non-saccharide sweetener used as a sugar substitute in some foods and beverages.
Purity : >98%(HPLC)
Size | Price / USD | Stock | Quantity |
500MG | 41 | In Stock |
|
1G | 56 | In Stock |
|
Biological Information
-
Product NameAspartame
-
NoteResearch use only, not for human use.
-
Brief DescriptionAspartame is an artificial, non-saccharide sweetener used as a sugar substitute in some foods and beverages.
-
DescriptionAspartame is an artificial, non-saccharide sweetener used as a sugar substitute in some foods and beverages.
-
SynonymsL-Aspartyl-L-Phenylalanine methyl ester
-
PathwayOthers
-
TargetOther Targets
-
RecptorTaste receptor; Transient receptor potential cation channel
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number22839-47-0
-
Formula Weight294.30
-
Molecular FormulaC14H18N2O5
-
Purity>98%(HPLC)
-
SolubilityWater: 4 mg/mL (13.59 mM); DMSO: 33 mg/mL (112.13 mM)
-
SMILESO=C(O)C[C@H](N)C(N[C@@H](CC1=CC=CC=C1)C(OC)=O)=O
-
Chemical Name(3S)-3-Amino-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
G280-9
The G280-9 peptide, a common melanoma gp100 epitope restricted by MHC-associated HLA-A2. The G280-9 sequence is unique because it could be recognized by cytotoxic T lymphocytes at very low concentrations, however it shows low total immunogenicity that may be attributable to relatively low affinity of this peptide for the HLA-A2.
-
1-(3,5-dimethoxy)phe...
1-(3',5'-dimethoxy)phenyl-2-[4''-O-β-D-glucopyranosyl (6→1)-O-α-L-rhamnopyranosyl]phenylethane showed cytotoxic activities to Hela and hep2 cell lines.
-
FEN1 Inhibitor C2
FEN1-IN-4 is an inhibitor of human flap endonuclease-1 (hFEN1)FEN1 Inhibitor C2 inhibition selectively impairs proliferation of colon cancer cells deficient in Cdc4 and Mre11a, both frequently mutated in colorectal cancers.?